UBQLN1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.502200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.736630E-01
Normal-vs-Stage2
6.797200E-01
Normal-vs-Stage3
1.211190E-01
Normal-vs-Stage4
2.552200E-01
Stage1-vs-Stage2
5.199600E-01
Stage1-vs-Stage3
5.736000E-03
Stage1-vs-Stage4
5.628000E-01
Stage2-vs-Stage3
6.631700E-02
Stage2-vs-Stage4
2.892200E-01
Stage3-vs-Stage4
3.564400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.660400E-01
Normal-vs-AfricanAmerican
6.196200E-01
Normal-vs-Asian
7.538200E-01
Caucasian-vs-AfricanAmerican
6.476600E-01
Caucasian-vs-Asian
8.474600E-01
AfricanAmerican-vs-Asian
6.677200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.340400E-01
Normal-vs-Female
6.734200E-01
Male-vs-Female
6.538400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.798600E-01
Normal-vs-Age(41-60Yrs)
2.911000E-01
Normal-vs-Age(61-80Yrs)
9.013800E-01
Normal-vs-Age(81-100Yrs)
8.084000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.851200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.904600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.871000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.981820E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.425760E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.236200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.886600E-01
Normal-vs-Daily Drinker
9.475400E-01
Normal-vs-Weekly Drinker
9.152400E-01
Normal-vs-Occasional Drinker
4.072800E-01
Normal-vs-Social Drinker
4.902600E-01
Non Drinker-vs-Daily Drinker
9.264800E-01
Non Drinker-vs-Weekly Drinker
8.759200E-01
Non Drinker-vs-Occasional Drinker
5.932500E-02
Non Drinker-vs-Social Drinker
1.830040E-01
Daily Drinker-vs-Weekly Drinker
9.322400E-01
Daily Drinker-vs-Occasional Drinker
8.884300E-02
Daily Drinker-vs-Social Drinker
1.907970E-01
Weekly Drinker-vs-Occasional Drinker
1.498160E-01
Weekly Drinker-vs-Social Drinker
2.939000E-01
Occasional Drinker-vs-Social Drinker
6.091000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.235000E-01
Normal-vs-Grade 2
7.116200E-02
Normal-vs-Grade 3
5.112500E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.054800E-01
Grade 1-vs-Grade 3
6.903400E-01
Grade 1-vs-Grade 4
2.235000E-01
Grade 2-vs-Grade 3
9.545600E-01
Grade 2-vs-Grade 4
7.116200E-02
Grade 3-vs-Grade 4
5.112500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.667800E-01
Normal-vs-NonDiabetic
6.544600E-01
Diabetic-vs-NonDiabetic
1.833180E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.719400E-01
Normal-vs-NoPancreatitis
6.873200E-01
Pancreatitis-vs-NoPancreatitis
9.960400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.864400E-01
Normal-vs-N1
6.897000E-01
N0-vs-N1
5.429200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.712400E-01
Normal-vs-TP53-NonMutant
6.634200E-01
TP53-Mutant-vs-TP53-NonMutant
1.061810E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
